PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

1.53 -0.09 (-5.26%)

As of 2026-03-03 13:30:50 EST

Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Traded asNasdaq: PACB
ISINUS69404D1081
CIK0001299130
LEI529900F1BWRE1M0KZN89
EIN161590339
Sector—
IndustryLaboratory Analytical Instruments
CEOChristian Henry
Employees575
Fiscal Year End1231
Address1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone650-521-8000
Websitehttp://pacb.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.2026-03-03 13:30:501.53-0.09-5.26
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
PACB0001299130PACIFIC BIOSCIENCES OF CALIFORNIA, INC.US69404D1081529900F1BWRE1M0KZN89161590339Nasdaq3826Laboratory Analytical Instruments1231DE1305 O'BRIEN DRIVEMENLO PARKCA94025UNITED STATESUS650-521-80001305 O'BRIEN DRIVE, MENLO PARK, CA, 940251305 O'BRIEN DRIVE, MENLO PARK, CA, 94025PACIFIC BIOSCIENCES OF CALIFORNIA INC—2004Christian Henry575http://pacb.com369,900,000301,956,000301,998,292Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.2026-02-26 18:39:16
This is a preview of the latest data. Subscribe to access the full data.
PACB Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
PACB Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025369,900,000-1,500,000-0.4039301,998,2924,146,0641.392
2024371,400,000-2,952,301,933-88.8257297,852,22829,900,34811.1588
20233,323,701,9332,331,833,424235.095267,951,88020,872,5068.4477
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Mark Van OeneChief Operating Officer2024601,97404,094,130108,90004,805,004
Jeff EidelChief Commercial Officer2024420,20802,367,6900545,2693,333,167
Christian O. HenryChief Executive Officer, President2024725,02508,237,595219,00009,181,620
Susan G. KimChief Financial Officer2024449,74302,219,710002,669,453
Jeff EidelChief Commercial Officer2023456,33301,832,108230,00015,2862,533,727
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2025485
2024575
2023796
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue160,005,000154,014,000200,521,000
Cost Of Revenue114,225,000116,732,000147,741,000
Gross Profit45,780,00037,282,00052,780,000
Research And Development Expenses97,307,000134,922,000187,170,000
General And Administrative Expenses141,493,000175,017,000169,818,000
Operating Expenses599,641,000511,595,000387,247,000
Operating Income-553,861,000-474,313,000-334,467,000
Net Income-546,376,000-309,851,000-306,735,000
Earnings Per Share Basic-1.82-1.13-1.21
Earnings Per Share Diluted-1.82-1.59-1.21
Weighted Average Shares Outstanding Basic299,959,000274,488,000253,629,000
Weighted Average Shares Outstanding Diluted299,959,000288,366,000253,629,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents63,707,00055,370,000179,911,000
Marketable Securities Current215,799,000334,561,000465,181,000
Accounts Receivable35,448,00027,524,00036,615,000
Inventories49,285,00058,755,00056,676,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current375,052,000495,681,000742,047,000
Marketable Securities Non Current——96,063,000
Property Plant And Equipment24,146,00030,505,00036,432,000
Other Assets Non Current8,773,0009,305,00013,274,000
Total Assets Non Current409,031,000764,766,0001,003,966,000
Total Assets784,083,0001,260,447,0001,746,013,000
Accounts Payable20,770,00016,590,00015,062,000
Deferred Revenue15,936,00013,864,00016,342,000
Short Term Debt—0490,000
Other Liabilities Current2,031,0003,224,0008,326,000
Total Liabilities Current72,831,00066,299,00095,029,000
Long Term Debt436,382,000435,494,000490,000
Other Liabilities Non Current0546,000751,000
Total Liabilities Non Current705,903,000687,554,000949,680,000
Total Liabilities778,734,000753,853,0001,044,709,000
Common Stock302,000294,000268,000
Retained Earnings-2,695,302,000-2,148,926,000-1,839,075,000
Accumulated Other Comprehensive Income457,000422,000219,000
Total Shareholders Equity5,349,000506,594,000701,304,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization369,400,00027,400,0008,300,000
Share Based Compensation Expense41,668,00071,036,00072,118,000
Other Non Cash Income Expense-1,688,000628,000—
Change In Accounts Receivable7,924,000-9,091,00017,829,000
Change In Inventories1,419,0008,320,00013,841,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable2,482,0001,405,000206,000
Change In Other Liabilities-1,193,000-4,612,00013,103,000
Cash From Operating Activities-111,209,000-206,058,000-259,173,000
Purchases Of Marketable Securities216,911,000498,635,000756,567,000
Sales Of Marketable Securities034,856,000595,000
Acquisition Of Property Plant And Equipment2,714,0006,188,0008,843,000
Acquisition Of Business00102,000
Other Investing Activities———
Cash From Investing Activities115,448,000124,004,0004,604,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock0015,319,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities3,428,0007,703,0000
Cash From Financing Activities3,428,000-42,987,000108,891,000
Change In Cash7,667,000-125,041,000-145,678,000
Cash At End Of Period63,707,00055,370,000179,911,000
Income Taxes Paid481,000——
Interest Paid8,264,00014,805,00015,687,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-1.82-1.13-1.21
Price To Earnings Ratio-1.0275-1.6195-8.1074
Earnings Growth Rate61.0619-6.6116-13.5714
Price Earnings To Growth Ratio-0.01680.24490.5974
Book Value Per Share0.01781.84562.7651
Price To Book Ratio104.86510.99153.5478
Ebitda-169,541,000-269,039,000-284,092,000
Enterprise Value933,598,330882,437,0402,309,169,490
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio81.5820.85970.0014
Capital Expenditures363,041,00021,473,0003,152,000
Free Cash Flow-474,250,000-227,531,000-262,325,000
Return On Equity-102.1454-0.6116-0.4374
One Year Beta1.67592.92752.3157
Three Year Beta2.10592.76092.7384
Five Year Beta2.48091.97031.7788
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Farmer Michele—2026-02-1814,952D219,092
HENRY CHRISTIAN O—2026-02-18140,874D2,673,500
Van Oene Mark—2026-02-1855,107D1,742,638
Farmer Michele—2026-02-1735,215D234,044
HENRY CHRISTIAN O—2026-02-17331,793D2,814,374
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Caitong International Asset Management Co., Ltd2025-12-3119,39410,3711.87
T. Rowe Price Investment Management, Inc.2025-12-311,0002174.6083
Invesco Ltd.2025-12-312,679,7301,433,0111.87
AXXCESS WEALTH MANAGEMENT, LLC2025-12-3153,48828,6031.87
MACKENZIE FINANCIAL CORP2025-12-3130,21417,4991.7266
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
RYDEX SERIES FUNDS2025-12-31Class CRYCMX384718.080.0085
RYDEX SERIES FUNDS2025-12-31Class ARYAKX384718.080.0085
RYDEX SERIES FUNDS2025-12-31Class HRYMKX384718.080.0085
RYDEX DYNAMIC FUNDS2025-12-31H-Class SharesRYRSX1,4082,632.960.0048
RYDEX DYNAMIC FUNDS2025-12-31C-Class SharesRYRLX1,4082,632.960.0048
This is a preview of the latest data. Subscribe to access the full data.